Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR
| Report ID | 225212 |
| Drug Identification Number | 02261847 |
| Brand name | SANDOZ-CARBAMAZEPINE CR |
| Common or Proper name | CARBAMAZEPINE CR |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | CARBAMAZEPINE |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100MRT |
| ATC code | N03AF |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-15 |
| Estimated end date | 2024-08-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-04-16 | French | Compare |
| v1 | 2024-04-16 | English | Compare |
Showing 1 to 2 of 2